Kevin Lee, Ph.D., MBA

Kevin Lee, Ph.D., MBA

Chief Executive OfficeratBicycle Therapeutics· In proxies 2022–2025

Pay in FY2025+31% from the year before · Bicycle Therapeutics stock -49.4% the same year

Kevin Lee, Ph.D., MBA was paid $6.3M in FY2025 (Dec), up 31%. Bicycle Therapeutics stock fell 49.4% that year.

Pay$100 in the stock at the end of FY21 → $19
Pay is from the Summary Compensation Table of each Bicycle Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Bicycle TherapeuticsPublic company · 4 yr
    • Chief Executive Officer2022 – Present · 4 yrStock in role -94%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?